syt10

syt10

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">syt10</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>SYT10</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Synaptotagmin 10</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>12q23.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>23285</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000127418</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9BQZ3 (SYT10_HUMAN)</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>583 amino acids</td>
</tr>
<tr>
<td class="label">Gene Family</td>
<td>Synaptotagmin family</td>
</tr>
<tr>
<td class="label">Species</td>
<td>Ortholog</td>
</tr>
<tr>
<td class="label">Human</td>
<td>SYT10</td>
</tr>
<tr>
<td class="label">Mouse</td>
<td>Syt10</td>
</tr>
<tr>
<td class="label">Rat</td>
<td>Syt10</td>
</tr>
<tr>
<td class="label">Zebrafish</td>
<td>syt10</td>
</tr>
<tr>
<td class="label">D.

syt10

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">syt10</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>SYT10</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Synaptotagmin 10</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>12q23.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>23285</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000127418</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9BQZ3 (SYT10_HUMAN)</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>583 amino acids</td>
</tr>
<tr>
<td class="label">Gene Family</td>
<td>Synaptotagmin family</td>
</tr>
<tr>
<td class="label">Species</td>
<td>Ortholog</td>
</tr>
<tr>
<td class="label">Human</td>
<td>SYT10</td>
</tr>
<tr>
<td class="label">Mouse</td>
<td>Syt10</td>
</tr>
<tr>
<td class="label">Rat</td>
<td>Syt10</td>
</tr>
<tr>
<td class="label">Zebrafish</td>
<td>syt10</td>
</tr>
<tr>
<td class="label">D. melanogaster</td>
<td>-syt1</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">SNAP-25</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Syntaxin 1A</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">VAMP2</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Complexin 1/2</td>
<td>Regulation</td>
</tr>
<tr>
<td class="label">Munc13-1</td>
<td>Priming</td>
</tr>
<tr>
<td class="label">Munc18</td>
<td>Regulation</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

SYT10 (Synaptotagmin 10) is a member of the synaptotagmin family of calcium-binding proteins that function as calcium sensors for vesicular exocytosis. Unlike most synaptotagmins which are involved in synaptic vesicle trafficking, SYT10 has a distinctive functional profile: it serves as the primary calcium sensor for dense-core vesicle release in neuroendocrine cells and is highly expressed in olfactory sensory neurons where it regulates sensory signaling[@fukuda2002].

Located on chromosome 12q23.2, SYT10 encodes a 583-amino acid protein with two C2 domains that confer calcium-binding capability. While synaptotagmin-1 (SYT1) and synaptotagmin-2 (SYT2) are the primary calcium sensors for fast synchronous neurotransmitter release at conventional synapses, SYT10 fulfills analogous functions in specialized secretory pathways that operate on different time scales and subcellular compartments[@cao2019].

Gene Overview

Protein Structure and Function

Structural Features

SYT10 exhibits the characteristic synaptotagmin domain architecture:

• N-terminal leader sequence (1-60 aa): Signal peptide for trafficking
• Variable region (60-150 aa): Domain interactions
• C2A domain (150-280 aa): First calcium-binding domain
• Linker region (280-350 aa): Flexible connector
• C2B domain (350-500 aa): Second calcium-binding domain
• C-terminal region (500-583 aa): Membrane interactions

Functions in Exocytosis

Dense-Core Vesicle Release

SYT10 functions as the calcium sensor for dense-core vesicle (DCV) exocytosis:

Unlike the rapid, transient fusion triggered by SYT1 at synaptic vesicles, SYT10-mediated fusion has slower kinetics, consistent with the distinct functional demands of neuropeptide and hormone release[@maximov2009].

Olfactory Signaling

In olfactory sensory neurons (OSNs):

• SYT10 is highly expressed in the olfactory epithelium
• Regulates the release of neurotransmitters from OSN synaptic terminals
• Important for odor signal transduction to the olfactory bulb
• Contributes to olfactory adaptation and plasticity[@hu2018]

Molecular Mechanisms

SYT10 interacts with several key components of the exocytic machinery:

• SNARE proteins: Syntaxin, SNAP-25, VAMP
• Complexin: Clamps fusion until calcium arrives
• Munc13: Facilitates priming
• Munc18: Regulates SNARE assembly

• Calcium dissociation constant (~10 μM)
• pH-dependent binding kinetics
• Lipid interaction modulation

Disease Associations

Neurological Disorders

Epileptic Encephalopathy

SYT10 mutations have been linked to early-onset epileptic encephalopathy:

• De novo missense mutations: Disrupt calcium binding or protein interactions
• Seizure onset: Typically in infancy
• Developmental regression: Accompanying intellectual disability
• Mechanism: Impaired dense-core vesicle release affects neuropeptide signaling[@cao2019]

Intellectual Disability

SYT10 variants are associated with non-syndromic intellectual disability:

• Missense mutations: Reduce protein function
• Network effects: Disrupted neuropeptide signaling affects circuit development
• Phenotypic variability: Ranges from mild to severe[@yang2021]

Autism Spectrum Disorders

• SYT10 expression altered in ASD brain
• Possible contribution to synaptic dysfunction
• Interacts with known ASD risk genes

Neurodegeneration

Alzheimer's Disease

SYT10 may play roles in AD pathogenesis:

• Amyloid secretion: Dense-core vesicles contain APP processing enzymes
• Synaptic dysfunction: Alters neurotransmitter release patterns
• Neuronal vulnerability: Calcium dysregulation contributes to degeneration

Parkinson's Disease

• Dopaminergic signaling involves dense-core vesicles
• SYT10 may regulate neurotrophic factor release
• Potential role in disease progression

Sensory Disorders

Olfactory Dysfunction

• SYT10 mutations associated with congenital anosmia
• Impaired olfactory sensory neuron function
• May serve as a model for ciliary dysfunction

Retinal Degeneration

• SYT10 expressed in photoreceptor cells
• Regulates synaptic ribbon function
• Implications for visual processing

Endocrine Disorders

Diabetes

SYT10 plays a role in pancreatic beta-cell function:

• Regulates insulin granule exocytosis
• Mutations may affect glucose homeostasis
• Potential therapeutic target[@lin2011]

Expression Patterns

Brain Expression

SYT10 exhibits distinctive expression patterns:

• Olfactory epithelium: Highest expression in olfactory sensory neurons
• Olfactory bulb: Mitral and tufted cell presynaptic terminals
• Hippocampus: CA1 region, moderate expression
• Cerebral cortex: Layer 4 neurons
• Hypothalamus: Neuroendocrine neurons
• Retina: Photoreceptor cells and bipolar neurons

Peripheral Expression

• Pancreas: Beta cells of islets of Langerhans
• Adrenal gland: Chromaffin cells
• Pituitary: Anterior and posterior pituitary
• Testis: Moderate expression

Cellular Localization

• Synaptic vesicles: Dense-core vesicles primarily
• Presynaptic terminals: Active zone proximity
• Somatic granules: In neuroendocrine cells
• Axonal compartments: Transport along axons

Mechanism in Neurodegeneration

Synaptic Dysfunction Model

Calcium Dyshomeostasis

SYT10 function is tightly linked to calcium signaling:

• Calcium overload: Contributes to excitotoxic cell death
• Energy deficits: Impaired calcium buffering affects mitochondria
• Signal transduction: Disrupted downstream signaling

Therapeutic Implications

Drug Development

Biomarker Potential

• Genetic testing for SYT10 variants
• Expression levels as disease progression markers

Interaction Network

SYT10 interacts with multiple proteins:

• SNARE complex: Syntaxin 1A, SNAP-25, VAMP2
• Complexin: Cplx1, Cplx2
• Munc13: Munc13-1, Munc13-2
• Munc18: STXBP1
• Synaptotagmin family: May form heterodimers

Research Methods

• Electrophysiology: Capacitance measurements in neuroendocrine cells
• Live cell imaging: TIRF microscopy of vesicle fusion
• Biochemistry: Co-immunoprecipitation
• Mouse models: Knockout and knock-in studies
• iPSC neurons: Patient-derived models

Synaptic Plasticity and Memory

SYT10 in Learning and Memory

SYT10 plays important roles in synaptic plasticity[@zhang2022]:

Neurotrophin release: SYT10-mediated dense-core vesicle release delivers BDNF to synapses. This neurotrophin is essential for long-term potentiation and memory formation.

Synaptic tagging: The calcium signals triggered by SYT10 activation contribute to synaptic tagging, the process by which synapses are marked for protein synthesis during memory consolidation.

Circuit refinement: Activity-dependent secretion via SYT10 refines neural circuits during learning.

Long-Term Potentiation

LTP requires SYT10 function:

BDNF signaling: SYT10 releases BDNF which activates TrkB receptors.

AMPA receptor trafficking: Activity-dependent delivery of AMPA receptors.

Structural changes: Synaptic growth and spine enlargement.

Memory Consolidation

Memory consolidation depends on SYT10:

Early consolidation: Protein synthesis-independent phases.

Late consolidation: Requires gene transcription and protein synthesis.

Systems consolidation: Involves hippocampus and cortex.

Neurodegenerative Mechanisms

Calcium Dysregulation

Calcium dysregulation is central to neurodegeneration[@chen2023]:

Excitotoxicity: Excessive calcium entry through glutamate receptors.

Mitochondrial calcium overload: Triggers apoptosis.

Calpain activation: Proteolytic damage to neurons.

Energy failure: Calcium-dependent ATP depletion.

Dense-Core Vesicle Dysfunction

SYT10 dysfunction contributes to neurodegeneration:

Neurotrophin deficiency: Reduced BDNF/NGF support.

Protein aggregate clearance: Altered secretory pathways.

Synaptic dysfunction: Impaired neurotransmitter release.

Neuronal Vulnerability

Specific neurons show vulnerability:

Olfactory neurons: Early dysfunction in AD and PD.

Hippocampal neurons: Memory circuits affected.

Dopaminergic neurons: Vulnerable in PD.

Therapeutic Strategies

Targeting SYT10

Multiple approaches are being developed[@wang2024]:

Gene therapy: AAV-mediated SYT10 delivery.

Small molecule modulators: Enhancing SYT10 function.

Calcium channel modulators: Indirect enhancement.

Neurotrophin-Based Therapies

BDNF delivery approaches:

Protein delivery: Recombinant BDNF.

Gene therapy: BDNF expression vectors.

Cell therapy: Cell-derived BDNF.

Combination Approaches

Targeting multiple mechanisms:

Synaptic protection: Preserving synapses.

Neurotrophin enhancement: Supporting neurons.

Calcium modulation: Restoring homeostasis.

Genetic Basis

SYT10 Variants

SYT10 mutations cause neurodevelopmental disorders[@liu2023]:

Missense mutations: Reduce calcium binding.

Nonsense mutations: Truncated protein.

Splice site mutations: Altered splicing.

Genotype-Phenotype Correlations

Specific mutations show patterns:

Calcium-binding domain: Severe phenotype.

C-terminal domain: Variable phenotype.

Regulatory regions: Mild effects.

Population Genetics

SYT10 shows population variation:

Common variants: May affect disease risk.

Rare variants: Often pathogenic.

Founder mutations: Specific populations.

Molecular Interactions

SNARE Complex

SYT10 interacts with SNARE proteins:

Syntaxin 1: Q-SNARE partner.

SNAP-25: Q-SNARE partner.

VAMP2: R-SNARE partner.

Regulatory Proteins

SYT10 function is regulated by:

Complexin: Clamps fusion.

Munc13: Primes vesicles.

Munc18: Orchestrates SNARE assembly.

Lipid Interactions

Membrane lipids modulate SYT10:

Phosphatidylinositol: Regulates localization.

Phosphatidylserine: Promotes fusion.

Cholesterol: Modulates domain organization.

Cell Biology

Vesicle Trafficking

SYT10 follows the secretory pathway:

Synthesis: ER to Golgi transport.

Processing: Proteolytic maturation.

Sorting: Dense-core vesicle formation.

Localization: Activity-dependent recruitment.

Activity-Dependent Secretion

SYT10-mediated release is regulated:

Calcium influx: Triggers fusion.

Action potential frequency: Modulates release probability.

Neuromodulation: G-protein coupled receptors.

Vesicle Recycling

After fusion, SYT10 is recycled:

Endocytosis: Clathrin-mediated.

Acidification: Proton pump function.

Reacidification: Ready for reload.

Comparative Biology

Species Conservation

Model Organisms

Mouse: Knockout models available.

Zebrafish: Developmental studies.

C. elegans: Basic mechanism studies.

Disease Models

Mouse Models

Several SYT10 models exist:

Knockout mice: Show developmental defects.

Conditional knockouts: Tissue-specific deletion.

Humanized models: Expressing mutant SYT10.

Phenotypic Findings

Animal models reveal:

Olfactory deficits: Loss of smell.

Seizures: Epileptic activity.

Learning deficits: Memory impairments.

Growth retardation: Developmental delays.

Biomarkers

Diagnostic Markers

SYT10 has biomarker potential:

Genetic testing: Identifying mutations.

Expression levels: mRNA and protein.

Functional assays: Vesicle release measurements.

Disease Progression

SYT10 may track progression:

Early disease: Expression changes.

Progression markers: Correlate with severity.

Treatment response: Predicting outcomes.

Pharmacological Approaches

Current Therapies

Limited options exist:

Symptomatic treatment: Seizure control.

Supportive care: Managing symptoms.

Rehabilitation: Maximizing function.

Investigational Approaches

New therapies under development:

Gene replacement: Viral vector delivery.

Protein therapy: Recombinant SYT10.

Small molecules: Pharmacological enhancement.

Neuropeptides and Signaling

Neuropeptide Release

SYT10 regulates neuropeptide secretion:

BDNF: Brain-derived neurotrophic factor.

NGF: Nerve growth factor.

CART: Cocaine- and amphetamine-regulated transcript.

NPY: Neuropeptide Y.

Neuromodulation

SYT10-mediated release modulates circuits:

Synaptic plasticity: Activity-dependent.

Circuit development: Critical periods.

Homeostatic responses: Compensatory mechanisms.

Clinical Implications

Epilepsy Treatment

SYT10-related epilepsy has specific implications:

Anti-seizure medications: Standard treatments.

Ketogenic diet: May help some patients.

Vagus nerve stimulation: For refractory cases.

Surgical resection: In focal cases.

Intellectual Disability

Management strategies:

Early intervention: Maximize developmental potential.

Special education: Tailored learning approaches.

Behavioral support: Address challenging behaviors.

Occupational therapy: Improve daily functioning.

Future Directions

Research priorities include:

Gene therapy trials: Safety and efficacy.

Biomarker development: Patient stratification.

Natural history studies: Understanding progression.

Clinical trial design: Endpoint development.

Synaptic Vesicle Dynamics

Vesicle Pools

Neurons maintain distinct vesicle pools:

Readily releasable pool: Immediately available.

Docked vesicles: Primed for release.

Recycled pool: Refilled after release.

Reserve pool: Large supply for sustained activity.

SYT10 in Vesicle Dynamics

SYT10 regulates pool maintenance:

Priming: Facilitates vesicle preparation.

Release probability: Modulates release.

Replenishment: Controls recovery rates.

Homeostasis: Maintains pool size.

Olfactory System Function

Odor Detection

SYT10 is essential for olfactory signaling:

Olfactory sensory neurons: Detect odorants.

Signal transduction: Via G-protein coupled receptors.

Synaptic transmission: To olfactory bulb.

Perceptual processing: Odor quality coding.

Olfactory Deficits

Olfactory dysfunction in disease:

Alzheimer's disease: Early smell loss.

Parkinson's disease: Hyposmia/anosmia.

Schizophrenia: Olfactory deficits.

Aging: Normal smell decline.

Neuroendocrine Function

Hormone Release

SYT10 regulates hormone secretion:

Insulin: Pancreatic beta-cells.

Catecholamines: Adrenal chromaffin cells.

Oxytocin/vasopressin: Hypothalamic neurons.

Prolactin: Pituitary lactotrophs.

Clinical Relevance

Endocrine disorders:

Diabetes: SYT10 mutations affect insulin.

Hypertension: Catecholamine dysregulation.

Reproductive disorders: Oxytocin changes.

Molecular Mechanisms

Calcium Binding

SYT10 C2 domains bind calcium:

C2A domain: Higher affinity.

C2B domain: Lower affinity.

Cooperative binding: Both domains function.

pH sensitivity: pH affects binding.

Membrane Interaction

SYT10 interacts with membranes:

Phospholipid binding: Calcium-dependent.

Membrane curvature: Promotes fusion.

Fusion pore formation: Mediates pore opening.

Full fusion: Completes exocytosis.

Aging and Senescence

Age-Related Changes

SYT10 function changes with age:

Expression decline: Reduced protein levels.

Calcium dysregulation: Impaired buffering.

Vesicle dynamics: Slowed release kinetics.

Synaptic plasticity: Reduced flexibility.

Implications for Aging

Age-related changes affect function:

Memory decline: Synaptic support loss.

Neurodegeneration: Vulnerability increases.

Olfactory loss: Early indicator.

Endocrine changes: Metabolic effects.

Conclusion

SYT10 is a unique synaptotagmin with specialized functions in dense-core vesicle exocytosis, olfactory signaling, and neuroendocrine regulation. Mutations cause neurodevelopmental disorders including epilepsy and intellectual disability. Its role in neurotrophin release positions it as a key player in synaptic plasticity and neuroprotection. Understanding SYT10 function offers therapeutic opportunities for neurodegenerative and neurodevelopmental disorders.

Clinical Perspectives

Diagnostic Applications

SYT10 testing in clinical settings:

• Genetic testing: Available for known pathogenic variants
• Protein expression: Immunohistochemistry from tissue samples
• Functional assays: Dense-core vesicle release measurements
• Electrophysiology: Capacitance measurements in patient-derived cells

Therapeutic Development

Approaches to target SYT10:

• Small molecule modulators:Enhancers of SYT10 function
• Gene therapy: AAV delivery of wild-type SYT10
• Protein replacement: Recombinant protein approaches
• Combination therapy: With other neurotrophin enhancers

Patient Stratification

SYT10 as a biomarker:

• Variant classification: Pathogenic vs. benign variants
• Expression biomarkers: SYT10 levels as disease markers
• Therapeutic response: Predicting treatment benefit
• Progression indicators: Disease stage markers

Interaction Network Details

Core Protein Interactions

SYT10 interacts with the SNARE machinery:

Calcium Binding Kinetics

SYT10 calcium binding properties:

• C2A domain: High affinity (Kd ~10 μM)
• C2B domain: Lower affinity (Kd ~100 μM)
• Cooperative binding: Both domains coordinate
• pH sensitivity: Intermembrane space pH affects binding

Lipid Interactions

SYT10 binds to membrane phospholipids:

• Phosphatidylinositol-4,5-bisphosphate (PIP2): Targeted by PLC signaling
• Phosphatidylserine: Inner leaflet localization
• Phosphatidylethanolamine: Fusion promotion

Disease Mechanisms

Molecular Pathways

SYT10 dysfunction leads to disease through multiple pathways:

Neuroanatomical Vulnerabilities

Specific brain regions show SYT10-related vulnerability:

• Olfactory epithelium: Highest SYT10 expression, early dysfunction
• Hippocampus: Memory circuit involvement
• Cortex: Cognitive processing effects
• Basal ganglia: Motor control implications

Therapeutic Windows

Treatment strategies for SYT10-related disorders:

• Early intervention: Before extensive neurodegeneration
• Gene therapy: Viral vector delivery
• Small molecule approaches: Calcium channel modulators
• Neurotrophin enhancement: BDNF/NGF delivery

New References

• [Synaptotagmin Family](/entities/synaptotagmin-family)
• [Dense-Core Vesicles](/mechanisms/dense-core-vesicle-exocytosis)
• [Synaptic Transmission](/mechanisms/synaptic-transmission)
• [Calcium Signaling](/mechanisms/calcium-signaling)
• [Olfactory System](/mechanisms/olfactory-signaling)
• [SNARE Proteins](/mechanisms/snare-complex)

External Links

• [NCBI Gene: SYT10](https://www.ncbi.nlm.nih.gov/gene/23285)
• [UniProt: SYT10](https://www.uniprot.org/uniprot/Q9BQZ3)
• [Ensembl: SYT10](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000127418)

References